Precose

Quick links to important sections

Precose

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Precose

Property Description
Active ingredient Acarbose (INN)
Form Oral tablet
Pharmacological class Alpha-glucosidase inhibitor (AGI)
Common use Supporting glycemic control in Type 2 diabetes
Origin Derived from a microbial fermentation process

The Identity and Classification of Precose (Acarbose)

Precose is the United States brand name for the prescription-only medication containing the active substance Acarbose. It is chemically a pseudotetrasaccharide, a specialized molecular structure derived from a specific microbial fermentation process, differentiating it from purely synthetic compounds. Acarbose is classified by health authorities as an Alpha-glucosidase inhibitor (AGI), a distinct category utilized in the management of Type 2 diabetes mellitus. This single-active-ingredient formulation is consistently supplied as an oral tablet for ingestion, and is clinically recognized for its specific application in controlling blood sugar.


Primary Action and General Therapeutic Purpose

The overall therapeutic purpose of Precose is to effectively manage postprandial blood glucose (sugar levels after eating) by modulating the rate of carbohydrate absorption. Acarbose achieves this through a well-established mechanism, acting as a competitive inhibitor of key enzymes, specifically the membrane-bound intestinal alpha-glucosidases. By temporarily blocking these digestive enzymes in the small intestine, Precose delays the breakdown of complex dietary starches and sucrose into simple glucose. This action results in a slower, more sustained entry of glucose into the bloodstream, a strategy which is necessary to mitigate the sharp rise in blood sugar typically observed immediately following a meal.


Differentiating Precose from Other Diabetes Medications

Acarbose occupies a unique position because its core function is restricted to the gut, meaning its mechanism is localized to the gastrointestinal tract, with minimal systemic absorption. Unlike other foundational oral antidiabetic drug classes, Acarbose does not stimulate the release of insulin or directly alter the sensitivity of peripheral tissues to insulin. This functional difference establishes Precose as a targeted, adjuvant therapy intended to specifically manage the metabolic impact of dietary carbohydrate load, often utilized when the primary goal is post-meal glucose reduction.

Regulatory References

  1. NIH StatPearls - Acarbose Mechanism of Action

What side effects are possible with Precose?

Official Safety Profile and Adverse Reactions

Precose's safety profile is characterized primarily by gastrointestinal adverse reactions, which are often related to the drug's mechanism of action in the intestines. These events tend to lessen over time with continued use.

Frequency-Classified Adverse Reactions

The following side effects are documented based on frequency observed in regulatory sources:

Frequency Adverse Reaction
Very Common (ge1/10) Flatulence, Diarrhea, Abdominal Pain
Common (ge1/100 to <1/10) Increase in Liver Transaminases (AST, ALT)
Uncommon Nausea, Vomiting, Dyspepsia
Rare Oedema, Jaundice

Serious and Post-Marketing Adverse Reactions

Although rare, serious safety events have been reported during post-marketing surveillance. These include cases of hepatitis (including rare reports of fulminant hepatitis, sometimes fatal) and gastrointestinal issues such as intestinal obstruction (ileus/subileus) and Pneumatosis Cystoides Intestinalis. Severe low blood sugar (hypoglycemia) may occur if Precose is used alongside other diabetes medicines like insulin or sulfonylureas.

Safety-Related Restrictions and Contraindications

Precose is strictly contraindicated (must not be used) in patients with severe kidney impairment, severe liver impairment, or existing chronic intestinal diseases associated with digestive or absorption disorders (e.g., inflammatory bowel disease, conditions predisposing to intestinal obstruction). Safety is not established for children under 18 or for use during pregnancy and breastfeeding.

If severe hypoglycemia occurs while taking Precose with other diabetes medicines, only glucose (dextrose) should be used for treatment, as table sugar (sucrose) may not be effective quickly.

Overdose and Emergency Response

Precose Overdose and when to seek help

The official regulatory profile for an overdose of Precose (Acarbose) is strictly defined by its localized action, focusing on transient gastrointestinal manifestations rather than systemic toxicity.

Overdose Manifestations Immediate Regulatory Actions
Overdosage may lead to transient increases in flatulence, diarrhea, and abdominal discomfort (meteorism). Contact a poison control center or emergency room at once in the event of any suspected overdose.
Official labeling confirms that overdose will not result in hypoglycemia when the medication is taken independently of other diabetes treatments. The patient must not be given drinks or meals containing complex carbohydrates for the next 4 to 6 hours following the overdosage.

Overdosage effects are typically transient and subside shortly. Exaggerated intestinal symptoms are not anticipated if the medication is taken independently of food, as the clinical presentation is reliant on the presence of carbohydrates in the digestive tract. The official prescribing information does not document severe or life-threatening systemic outcomes resulting directly from acute oral tablet overdose. It is documented that no specific antidote is known for Acarbose. Urgent medical attention is required for assessment and to implement the immediate, regulator-mandated carbohydrate restriction. Management of any resulting gastrointestinal symptoms should follow standard conservative measures.

Therapeutic Uses of Precose

Precose (Acarbose) provides focused therapeutic support in the chronic management of Type 2 diabetes mellitus and is considered relevant for support in managing glucose control related to carbohydrate intake. The therapeutic use of this medicine is for the treatment of Type 2 diabetes, generally in conjunction with diet, exercise, and often, other medications.


This medication is used to manage hyperglycemic excursions, the excessive and rapid rise in blood sugar that occurs following a meal, particularly those containing complex carbohydrates. Its therapeutic domains of use are applied in addressing post-meal blood sugar spikes and contributing to the management of overall glycemic control.

Precose is generally applied as an adjuvant agent for adults with diabetes who require supplemental support to achieve blood sugar management goals. This targeted approach may assist with addressing chronically elevated blood glucose indicators, such as glycated hemoglobin (A1c). It helps patients cope more steadily with symptom fluctuations and contributes to easing the overall symptom load.

“This therapy is used to help moderate the impact of meal-related physiological changes, which may assist in supporting a sense of stability.”

Quick Fact: Support for Post-Meal Spikes This therapy is relevant in clinical scenarios where the patient's metabolic profile necessitates targeted support to address persistent, high blood sugar patterns linked to the processing of food, providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview on Acarbose

Eligibility and Restrictions for Use

Precose (Acarbose) is indicated for use in adults to improve blood sugar control as an adjunct to diet and exercise for individuals with Type 2 diabetes mellitus. Use is defined by a strict set of regulatory limitations, primarily related to gastrointestinal health.

Contraindicated Populations

Use is contraindicated (absolutely prohibited) in patients with the following conditions:

  • Known hypersensitivity to acarbose.
  • Diabetic ketoacidosis or established cirrhosis.
  • Chronic intestinal diseases, including inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or conditions that worsen due to increased gas formation.

Populations with Restrictions

Population Regulatory Status Official Basis
Pediatric Patients (lt 18 years) Not Recommended Safety and effectiveness have not been established.
Pregnant Patients Not Recommended Safety has not been established in this population.
Nursing Mothers Not Recommended Use is not recommended while breastfeeding.
Severe Renal Impairment Not Recommended Use is not recommended in patients with serum creatinine > 2.0 mg/dL (due to insufficient study data).

Precose is also not recommended for the treatment of Type 1 diabetes mellitus.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Precose (Acarbose) as defined in government regulatory labeling.

Documented Interaction Patterns

Interaction Type Interacting Substance/Product Official Regulatory Outcome/Restriction
Pharmacodynamic Additivity Other antidiabetic agents (e.g., Insulin, Sulfonylureas) Co-administration has an additive effect on lowering blood glucose, which requires recognition of an increased potential for hypoglycemia.
Altered Bioavailability Metformin, Digoxin Alters the systemic exposure of these co-administered drugs, officially leading to a reduction in their peak plasma concentration (Cmax) and overall exposure (AUC).
Functional Antagonism Intestinal Adsorbents (e.g., Charcoal) and Digestive Enzyme Preparations These products must not be co-administered as they may reduce the therapeutic effect of Acarbose.
Functional Counteraction Drugs that increase blood glucose (e.g., Corticosteroids) These agents can antagonize the action of Acarbose, potentially leading to a loss of overall glycemic control.

Timing and Population-Specific Constraints

Interactions with sucrose (cane sugar) can result in pronounced gastrointestinal discomfort and diarrhea due to increased fermentation of undigested carbohydrates. Furthermore, Acarbose use is formally contraindicated in patients with severe renal impairment (creatinine clearance less than 25 mL/min), as this condition increases the systemic exposure of the drug and its metabolites. The interaction profile is defined by these additive glucose-lowering effects and specific bioavailability changes for co-administered medicines, alongside mandatory separation from certain digestive aids.

Mechanism of Action

Ontology: How Precose Works

Inhibition of Intestinal Alpha-Glucosidases

This mechanism involves the drug acting as a competitive inhibitor of key digestive enzymes, primarily alpha-glucosidases, found on the small intestine's brush border. By binding to these targets, the drug directly interferes with the breakdown of complex carbohydrates (starches and disaccharides) into simple, absorbable sugars . This initial molecular action is localized to the gut and forms the foundation of the drug's physiological effect profile.


Modulation of Glucose Absorption Dynamics

The core pathway affected is the Gastrointestinal Carbohydrate Digestion Pathway. By slowing down the enzymatic process, the drug fundamentally alters the kinetics of glucose entry into the systemic circulation. This action leads to a delayed and reduced rate of glucose absorption, which is the physiological cascade that produces a flatter, more controlled blood glucose profile immediately following a meal.


Blunting of Post-Meal Glucose Excursion

The systemic consequence of the slowed absorption rate is the blunting of the postprandial glucose spike. This mechanism limits the impact of excessive glucose mediator activity on the body, modifying the endocrine response by reducing the sharp, immediate demand for a high insulin surge after consuming carbohydrates.

Dosage and Administration Information

Precose (acarbose) is administered as an oral tablet in strengths of 25 mg, 50 mg, and 100 mg, and is intended for continuous long-term use. The official usage protocol mandates a frequency of three times daily (t.i.d.).

Critical to the drug's labeled usage is the timing of administration: the tablet must be ingested at the start, precisely with the first bite, of each main meal. The tablet may either be swallowed whole with a small amount of liquid or chewed along with the first mouthful of food. Treatment typically begins with a low starting dose of 25 mg t.i.d. The dosage is highly individualized and is adjusted gradually over time, usually at intervals of four to eight weeks, to determine the maintenance level.

Established protocols outline strict maximum dose limits that are often dependent on patient body weight: patients weighing 60 kg or less have a maximum prescribed dose of 50 mg t.i.d., while patients over 60 kg have a maximum of 100 mg t.i.d. If a dose is missed, it should not be taken between meals. Instead, the missed dose is to be taken with the next main meal in the regular schedule; doses must not be doubled. Furthermore, use is generally not recommended in the pediatric population (under 18 years of age) or in patients with severe renal impairment.

Recent Clinical Evidence

Precose: Recent Clinical Evidence

Evidence for Glycemic Control

Numerous Randomized Controlled Trials (RCTs) and systematic reviews have research examined Acarbose for managing overall blood sugar in adults with Type 2 diabetes. These studies monitored key outcomes like glycated hemoglobin (A1c) and Fasting Plasma Glucose (FPG) over intermediate periods, typically ranging from six months to one year. Findings describe patterns observed in the studies where participants experienced measurable shifts in these markers. However, long-term effects are not fully established regarding sustained control over many years, and research exploring head-to-head comparisons with some of the newer diabetes medications is limited.


Evidence for Post-Meal Glucose Regulation

Research has also focused on the effect studied on post-meal blood sugar levels. Short-term RCTs and metabolic studies monitored patterns related to the elevation of blood sugar following a meal. Some findings described this elevation as less pronounced in the observed participants compared to control groups. However, the acute findings may be sensitive to the type of carbohydrates consumed, and data are still emerging regarding the long-term clinical relevance of this measured effect on post-meal spikes related to functional outcomes.


Extended Studies and Research Gaps

Acarbose was evaluated in extended-duration trials (e.g., 3-6 years) that focused on evaluating the incidence of cardiovascular events, often including individuals with impaired glucose tolerance (IGT). While studies tracking these events show patterns related to the incidence of cardiovascular events, certainty remains low when applying these findings broadly to all patients with Type 2 diabetes. Additionally, data are insufficient for certain groups, such as pediatric populations, and follow-up durations were limited in many primary efficacy studies.

Frequently Asked Questions (FAQ)

Common questions about Precose (FAQ)


Q: How quickly does Precose start to work?

Precose is a drug that works locally in the digestive system, meaning its action begins immediately with the first bite of the meal you take it with. According to official product information, its effect is primarily focused on slowing the digestion of that specific meal's carbohydrates. The overall duration of its activity in the body is described as being up to six hours.


Q: Can Precose cause stomach issues or gas?

Yes, official regulatory safety data describes gastrointestinal side effects like flatulence (gas), diarrhea, and abdominal pain as very common. These effects are related to the drug's mechanism of action, which involves blocking enzymes that digest carbohydrates. This causes undigested carbohydrates to ferment in the lower gut.


Q: Is it normal to feel bloated when first taking Precose?

Official safety documents indicate that gastrointestinal symptoms such as bloating and flatulence are most frequent when treatment begins. However, regulatory sources also document that these initial symptoms are typically mild to moderate in intensity and tend to lessen and improve over time with continued, regular use of the medication.


Q: What happens if I forget to take a dose of Precose?

Regulatory directions for a missed dose are clear because the drug must be taken with a meal to work properly. Official prescribing information states that if you forget a dose, you should not take it in between meals. Instead, the dose is to be taken with the next main meal in your regular schedule, and doses must not be doubled.


Q: What is the main benefit of using Precose instead of other drugs?

Precose's therapeutic action involves delaying and reducing the absorption of glucose directly from the gut. By targeting this process, the drug helps to significantly flatten the sharp rise in blood sugar that typically occurs immediately after a meal (postprandial glucose). This action results in a measured reduction in overall blood sugar control, known as glycosylated hemoglobin (A1c) levels.


Q: Does Precose affect other medications I take for high blood pressure?

Regulatory labeling states that certain drugs that increase blood glucose (like some corticosteroids and diuretics) may counter the blood-sugar-lowering effect of Precose. Official documentation outlines specific interaction patterns for certain classes of co-administered drugs.


Q: Does Precose interact with alcohol consumption?

While the regulatory Interactions section does not list a specific drug interaction between Precose and alcohol, official documentation includes a general warning for all people with diabetes. This general warning states that alcohol consumption may impact blood sugar levels, potentially causing either low blood sugar (hypoglycemia) or high blood sugar, and is a consideration noted in regulatory documentation for individuals managing diabetes.


Q: Do research studies show that Precose helps prevent long-term complications?

The effect of this medication on long-term clinical outcomes, such as the incidence of cardiovascular events, has been examined in clinical studies. However, official regulatory reviews note that the certainty of applying these specific long-term findings broadly to all patients with Type 2 diabetes remains low.


Q: What does official documentation say about the safety of Precose?

Official safety reviews summarize that the drug's overall adverse experience profile is primarily characterized by effects localized to the gastrointestinal system, such as flatulence, diarrhea, and bloating. These side effects are generally mild to moderate in intensity and are officially documented to tend to improve with continued, regular use over time.


Q: Is Precose known to cause weight loss?

Official regulatory reviews of clinical trial data indicate that when Precose is used alone (monotherapy), it is not associated with any significant change in weight. Its main therapeutic effect is focused on blood sugar control, not weight management.


Q: Can Precose cause problems with the liver?

Official information states that the drug must not be used (is contraindicated) in patients with established cirrhosis or severe liver impairment. Additionally, due to potential side effects, official guidance recommends regular monitoring of liver enzyme levels during the first year of treatment and periodically thereafter.


Q: What is the difference between Precose and Metformin?

Precose (acarbose) is classified as an alpha-glucosidase inhibitor that works locally in the small intestine to delay the absorption of glucose from food. In contrast, Metformin (a drug from the biguanide class) primarily works systemically by reducing the amount of glucose produced by the liver and increasing the body’s sensitivity to insulin.


Q: Are there any common foods or drinks that interact with Precose?

The most common food substance explicitly addressed in the official Interactions section is sucrose, commonly known as table sugar or cane sugar. Consuming sucrose can increase gastrointestinal discomfort because the drug prevents its proper digestion, leading to increased fermentation of the sugar in the colon.


Q: How long can I expect to take Precose?

Official prescribing information formally designates Precose for continuous long-term use. It is intended to be a supplementary treatment taken as an adjunct to diet and exercise in the management of Type 2 diabetes.


Q: Will taking Precose mean I can stop exercising?

According to the official indications for use, Precose is prescribed to improve blood sugar control as an adjunct to diet and exercise. This establishes the drug's role as a supplementary treatment that is used alongside these lifestyle modifications.


Q: Does taking Precose affect my cholesterol levels?

Clinical studies have examined the drug's effects on blood lipids. While some data describe a decrease in triglycerides and the ratio of low-density to high-density lipoprotein cholesterol, the drug is not specifically indicated or prescribed for the treatment of high cholesterol or lipid disorders.


Q: What is the typical timeframe for seeing effects from Precose?

The drug’s immediate effect of blunting post-meal blood glucose occurs right away. For evaluating its long-term effect on overall blood sugar control (A1c), official dosing guidelines state that the dosage is typically adjusted at 4–8 week intervals. This timeframe reflects how long it takes to assess the full long-term therapeutic effect.


Q: Does Precose have to be taken exactly at the same time every day?

The regulatory instruction mandates that the drug be taken three times daily, specifically at the start (with the first bite) of each main meal. The drug's therapeutic efficacy is tied to the timing of your carbohydrate ingestion, not a fixed clock time like 8:00 AM every day.


Q: Are there any known drug interactions that make Precose less effective?

Yes, regulatory documents state that certain substances must be avoided because they can reduce the therapeutic effect of Precose. These include intestinal adsorbents (such as charcoal) and digestive enzyme preparations, which should not be co-administered.


Q: Does the efficacy of Precose depend on the type of diet I follow?

Because the drug's mechanism of action is to delay the digestion of carbohydrates, official clinical notes indicate that the amount of starch and carbohydrate content in the diet being followed may influence how effective the drug is at lowering post-meal blood sugar.


Q: Are there studies on combining Precose with other oral medications?

Yes, the regulatory labeling indicates that the drug can be used in combination with other oral antidiabetic agents or insulin. Clinical studies have examined its effects when the drug is used as an adjunct to these other medications.

How should Precose be stored and disposed of?

Official Storage and Disposal Instructions

The storage and disposal requirements for Precose (Acarbose) tablets are strictly defined by regulatory authorities to ensure product stability and safety. The following rules are based on official government labeling:


Storage Conditions

  • Temperature: Store at room temperature (20 C to 25 C / 68 F to 77 F). Do not store above 25 C.
  • Protection: The tablets must be protected from freezing, excess heat, moisture, and direct light. Do not store the medication in the bathroom.
  • Packaging: Keep Precose in the original container, and ensure it is tightly closed to maintain product integrity.
  • Child Safety: Always keep the medication out of the reach and sight of children, storing it in an up and away location.

Disposal Requirements

  • Outdated Product: Do not use or keep medicine after its expiry date.
  • Disposal Method: Disposal is required to be done in accordance with local regulations (e.g., take-back programs). Do not flush the medication down the toilet or dispose of it via household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Precose found in:

A-Z Index: